0
About the Cover
RSSRSS   Get Alerts
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

May-June 2012

| Vol. 52. No. 3

Research

Susan J. Blalock, PhD; San Keller, PhD; David Nau, PhD, BSPharm, CPHQ; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.10149

Objectives  To develop and test a tool for obtaining patient evaluations of the quality of pharmacy services provided in ambulatory ...

[Continue Reading]
Tags: pharmaceutical services, telephone, surveys
Suzan N. Kucukarslan, PhD; Leslie A. Shimp, PharmD, MS; Nancy J. W. Lewis, PharmD, MPH; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.10201

Objectives  To identify unmet needs of patients taking medications for chronic health conditions and identify medication-related services that patients with ...

[Continue Reading]
Tags: pharmacotherapy, chronic disease, prescription drug, medication therapy management
Elizabeth A. Cook, MS; Karen B. Farris, PhD; Elizabeth Chrischilles, MS, PhD; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.10219

Objective  To describe the relationship between the availability and accessibility of contraceptives in Iowa pharmacies and the extent to which ...

[Continue Reading]
Tags: contraceptive agents
Jennifer McIntosh, PharmD, MHS; Lenore Tsikitas, MPH; Amanda Dennis, MBE; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.11033

Objectives  To determine the experiences of low-income women who were eligible for government-subsidized health insurance and seeking contraception in community ...

[Continue Reading]
Tags: contraceptive methods, family planning, insurance, women, low income
Jessica M. Bellone, PharmD, BCACP; Jamie C. Barner, PhD, BSPharm; Debra A. Lopez, PharmD, CDE, BCACP; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.10172

Objectives  To determine whether a difference exists in hospital readmission rates at 60 days postdischarge between patients who saw (intervention ...

[Continue Reading]
Tags: patient readmission

Research Notes

Jasmine Gonzalvo, PharmD; Andrew Schmelz, PharmD; Karen Suchanek Hudmon, DrPH, MS; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.10153

Objectives  To estimate the prevalence of community pharmacists and technicians who are capable of communicating with patients in Spanish and ...

[Continue Reading]
Tags: languages, needs assessment, community pharmacist
Suzanne Higginbotham, BS, PharmD, BCACP; Autumn Stewart, PharmD, BCACP; Andrea Pfalzgraf, MPH, PhD; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.10083

Objectives  To describe the immunization needs of indigent community-dwelling patients from a primary care center for the medically underserved, evaluate ...

[Continue Reading]
Tags: adult immunization, immunization, vaccination, vaccines

Reviews

John R. Horn, PharmD, FCCP; Maria Marzella Mantione, PharmD, CGP; John F. Johanson, MD, MSc, FACP, FACG; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.10161

Objectives  To define constipation, assess the pharmacist's role in identifying and treating constipation, and review clinical evidence for the efficacy, ...

[Continue Reading]
Tags: constipation, drugs, non-prescription, laxative, polyethylene glycol 3350
Sarah L. Cutrona, MD, MPH; Niteesh K. Choudhry, MD, PhD; Michael A. Fischer, MD, MS; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.10211

Objectives  To determine whether adherence interventions should be administered to all medication takers or targeted to nonadherers.

Data sources and ...

[Continue Reading]
Tags: diabetes mellitus, cardiovascular agents, diabetes mellitus, type 2, counseling, feedback, medication adherence ...

Experience

Annie Lam, BS, PharmD, CGP, FASCP; Peggy Soule Odegard, BS, PharmD, BCPS, CDE, FASCP; Jacqueline Gardner, PhD; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.10059

Objective  To describe a school of pharmacy–community pharmacy collaborative model for medication therapy management (MTM) service and training.

Setting  University ...

[Continue Reading]
Tags: program development, medication therapy management

Letters

Ana Lucia Hincapie, MS; Terri L. Warholak, BSPharm, PhD
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.11056
The Institute of Medicine 1999 report To Err is Human: Building a Safer Health System highlighted the dangers and the costs of ... [Continue Reading]
Tags: drug prescribing error, electronic prescribing
Toyin Tofade, MS, PharmD, BCPS, CPCC; John Hedrick; Steve Dedrick, MS; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.11251
Continuing professional development (CPD) is “a self-directed, ongoing, systematic and outcomes-focused approach to learning and professional development.”+1 CPD is incorporated into pharmacy ... [Continue Reading]
Tags: licensure

Association Report

Sara J. White, MS, FASHP; Noel E. Wilkin, BSPharm, PhD, FAPhA; Sara R. McElroy; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.12515
Tags: attitude, students, pharmacy, association of schools of public health, advocacy, american society ...

JAPhA Centennial

J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.12519
Editor's note: This is the first of four landmark articles being republished in JAPhA as part of the Journal's centennial celebration. In ... [Continue Reading]
Tags: ephedra, ephedra sinica

Vaccine Update

Haley Armstrong; Stephan L. Foster, PharmD, FAPhA
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.12516
Measles is a highly contagious vaccine-preventable disease that still causes epidemics around the world. Because of the highly contagious nature of this ... [Continue Reading]
Tags: measles

New Drugs

Daniel A. Hussar, PhD; Samuel P. Eckel
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.12517
Cystic fibrosis affects approximately 30,000 individuals in the United States and is the most common fatal genetic disease among whites. It is ... [Continue Reading]
Tags: cystic fibrosis, actinic keratosis, ingenol mebutate, ivacaftor, vismodegib

Science Snippets

L. Douglas Ried, PhD
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2012.12518
Vouri et al.+1 concluded that “improvement in the proportion of diabetes patients attaining A1c, blood pressure, and cholesterol [ABC] goals followed the ... [Continue Reading]
Tags: diabetes mellitus, drug delivery, targeted, cost-effectiveness analysis, abcs (adequacy and alignment, bones, ...
Abstract
close X
Advertisement